Estradiol

Estradiol: Drug Information

Estradiol: Drug Information

Navigation
1. Drug Name
2. Pharmacological Class
3. Mechanism of Action
4. Indications
5. Dosage and Administration
6. Pharmacokinetics
7. Contraindications
8. Warnings and Precautions
9. Side Effects
10. Drug Interactions
11. Pregnancy and Lactation
12. Patient Counseling Information

1. Drug Name

Generic Name

Estradiol

Brand Name(s)

  • Pakistan: Estranon
  • India: Progynova, Estragyn
  • US: Estrace, Climara, Vivelle-Dot
  • UK: Estraderm, Estrogel

2. Pharmacological Class

Class

Estrogen

Subclass

Steroidal estrogen

3. Mechanism of Action

Estradiol is a natural estrogen hormone and acts by binding to and activating the estrogen receptors (ERα and ERβ). This leads to the modulation of various physiological processes in the body.

4. Indications

Primary Indications

  • Menopausal symptoms: Treatment of hot flashes, vaginal dryness, and other symptoms of menopause.
  • Postmenopausal osteoporosis: Prevention of osteoporosis in postmenopausal women.
  • Estrogen deficiency: Replacement therapy in women with ovarian failure or other conditions that cause estrogen deficiency.

Off-label Uses

  • Contraception: Estradiol is sometimes used in combination with progestins for contraception.
  • Hormone replacement therapy (HRT) in transgender women

5. Dosage and Administration

Standard Dosage

For oral tablets (Estrace):

  • Menopausal symptoms: 0.5-2 mg daily, adjusted based on response and severity of symptoms.
  • Postmenopausal osteoporosis: 1-2 mg daily, depending on risk factors.

For transdermal patches (Climara, Vivelle-Dot):

  • Menopausal symptoms: 0.025-0.1 mg/day applied to the skin twice weekly.

Route of Administration

Oral (tablets), Transdermal (patches), Intravaginal (cream, ring)

Special Populations

  • Pediatric: Not indicated for use in children.
  • Geriatric: Use with caution in elderly patients, adjust dosage based on individual response and risk factors.

6. Pharmacokinetics

Absorption

Well-absorbed after oral administration.

Distribution

Widely distributed throughout the body, including the CNS. Protein binding is high (about 98%).

Metabolism

Metabolized in the liver, primarily by cytochrome P450 enzymes.

Excretion

Excreted in the urine, primarily as conjugated metabolites.

Half-life

Elimination half-life is approximately 13-20 hours.

7. Contraindications

  • Known or suspected breast cancer or estrogen-dependent tumors
  • Undiagnosed abnormal genital bleeding
  • Active thrombophlebitis or thromboembolic disorders
  • Severe liver dysfunction

8. Warnings and Precautions

  • Increased risk of endometrial cancer
  • Increased risk of cardiovascular events, including stroke and deep vein thrombosis
  • Monitor for signs of estrogen-related adverse effects

9. Side Effects

Common Side Effects

  • Headache
  • Breast tenderness
  • Nausea

Serious Side Effects

  • Endometrial hyperplasia or cancer
  • Cardiovascular events
  • Cholestatic jaundice

10. Drug Interactions

Major Interactions

  • Warfarin
  • Rifampin

Moderate Interactions

  • Phenytoin
  • St. John's Wort

Minor Interactions

  • Ascorbic acid (Vitamin C)
  • Acetaminophen

11. Pregnancy and Lactation

Pregnancy Category

Category X - Contraindicated during pregnancy.

Breastfeeding Considerations

Not recommended during breastfeeding. Small amounts of estradiol may pass into breast milk.

12. Patient Counseling Information

  • Take as directed and do not exceed prescribed dose.
  • Report any unusual vaginal bleeding or symptoms immediately.
  • Discuss contraceptive options and potential side effects with your healthcare provider.

Post a Comment

Previous Post Next Post